MA
MDT icon

Montag & Associates’s Medtronic MDT Stock Holding History

Montag & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$679K Buy
7,778
+90
+1% +$8.62K 0.03% 277
2025
Q4 		$744K Sell
7,688
-175
-2% -$17K 0.03% 262
2025
Q3 		$754K Buy
7,863
+619
+9% +$56.9K 0.03% 269
2025
Q2 		$637K Sell
7,244
-761
-10% -$64.5K 0.03% 285
2025
Q1 		$725K Buy
8,005
+480
+6% +$43K 0.04% 273
2024
Q4 		$606K Sell
7,525
-29
-0.4% -$2.51K 0.03% 303
2024
Q3 		$685K Sell
7,554
-1,585
-17% -$133K 0.03% 286
2024
Q2 		$725K Sell
9,139
-411
-4% -$33.7K 0.04% 266
2024
Q1 		$838K Buy
9,550
+417
+5% +$35.6K 0.04% 266
2023
Q4 		$758K Sell
9,133
-1,048
-10% -$79.9K 0.04% 263
2023
Q3 		$804K Buy
10,181
+667
+7% +$55.8K 0.05% 244
2023
Q2 		$844K Sell
9,514
-1,300
-12% -$112K 0.05% 231
2023
Q1 		$878K Sell
10,814
-651
-6% -$53.1K 0.06% 218
2022
Q4 		$898K Sell
11,465
-1,689
-13% -$137K 0.06% 214
2022
Q3 		$1.07M Buy
13,154
+1,024
+8% +$92K 0.07% 191
2022
Q2 		$1.1M Sell
12,130
-666
-5% -$67.5K 0.07% 200
2022
Q1 		$1.42M Sell
12,796
-826
-6% -$87.3K 0.08% 198
2021
Q4 		$1.41M Sell
13,622
-340
-2% -$39.4K 0.07% 206
2021
Q3 		$1.75M Sell
13,962
-121
-0.9% -$15.7K 0.09% 175
2021
Q2 		$1.75M Hold
14,083
– – 0.09% 180
2021
Q1 		$1.66M Sell
14,083
-956
-6% -$112K 0.09% 182
2020
Q4 		$1.76M Sell
15,039
-450
-3% -$49.5K 0.11% 165
2020
Q3 		$1.61M Sell
15,489
-2,186
-12% -$220K 0.13% 154
2020
Q2 		$1.62M Sell
17,675
-14,456
-45% -$1.39M 0.14% 134
2020
Q1 		$2.9M Sell
32,131
-3,490
-10% -$371K 0.29% 90
2019
Q4 		$4.04M Buy
35,621
+617
+2% +$67.7K 0.32% 86
2019
Q3 		$3.8M Buy
35,004
+5,192
+17% +$542K 0.33% 78
2019
Q2 		$2.9M Buy
29,812
+15,046
+102% +$1.37M 0.26% 94
2019
Q1 		$1.34M Sell
14,766
-24,400
-62% -$2.18M 0.12% 150
2018
Q4 		$3.56M Sell
39,166
-10,673
-21% -$997K 0.38% 70
2018
Q3 		$4.9M Buy
49,839
+41,165
+475% +$3.81M 0.43% 59
2018
Q2 		$743K Buy
8,674
+524
+6% +$43.8K 0.08% 181
2018
Q1 		$654K Buy
8,150
+394
+5% +$32.5K 0.07% 200
2017
Q4 		$626K Buy
7,756
+246
+3% +$19.7K 0.06% 202
2017
Q3 		$584K Buy
7,510
+885
+13% +$73.5K 0.06% 184
2017
Q2 		$588K Buy
6,625
+2,074
+46% +$175K 0.07% 176
2017
Q1 		$367K Sell
4,551
-250
-5% -$19.5K 0.04% 198
2016
Q4 		$342K Buy
4,801
+250
+5% +$19.6K 0.04% 204
2016
Q3 		$393K Hold
4,551
– – 0.05% 190
2016
Q2 		$395K Hold
4,551
– – 0.05% 186
2016
Q1 		$341K Sell
4,551
-500
-10% -$37.7K 0.05% 191
2015
Q4 		$389K Sell
5,051
-536
-10% -$40.3K 0.06% 180
2015
Q3 		$374K Sell
5,587
-1,878
-25% -$138K 0.06% 179
2015
Q2 		$553K Hold
7,465
– – 0.08% 169
2015
Q1 		$582K Buy
7,465
+71
+1% +$5.38K 0.08% 174
2014
Q4 		$534K Sell
7,394
-64
-0.9% -$4.45K 0.08% 172
2014
Q3 		$462K Sell
7,458
-300
-4% -$19.1K 0.08% 178
2014
Q2 		$495K Hold
7,758
– – 0.08% 180
2014
Q1 		$477K Hold
7,758
– – 0.08% 167
2013
Q4 		$445K Buy
7,758
+400
+5% +$22.7K 0.08% 167
2013
Q3 		$392K Sell
7,358
-250
-3% -$13.5K 0.07% 166
2013
Q2 		$392K Buy
+7,608
New +$376K 0.08% 159

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Montag & Associates's MDT Position: Q1 2026 in Review

Montag & Associates increased its Medtronic (MDT) stake by 1.2% in Q1 2026, buying an estimated $8.62K and bringing the position to 7,778 shares worth $679K. The position accounts for 0.03% of the portfolio, ranked #277.

Montag & Associates first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.9M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Montag & Associates held 7,778 shares of Medtronic worth $679K as of Q1 2026.
  • Montag & Associates bought 90 Medtronic shares in Q1 2026, an estimated $8.62K.
  • Medtronic made up 0.03% of Montag & Associates's portfolio in Q1 2026, its #277 holding.
  • Montag & Associates first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Montag & Associates's Medtronic position peaked at $4.9M in Q3 2018.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.